Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
760.00 | -48.06% | -26.74% | 684,308.09 | 0.67% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
149.91 | 0% | 0% | 360,785.28 | 3.31% | 2.71% |
|
NYSE:MRK
Merck
|
130.06 | -9.24% | 4.07% | 329,416.79 | 2.37% | -19.03% |
|
NYSE:PFE
Pfizer
|
28.01 | 10.84% | 41.72% | 158,721.27 | 5.96% | -9.31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
422.78 | 3.08% | 11.25% | 109,099.81 | 0% | 30.14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
973.80 | -28.98% | -22.93% | 105,058.9 | 0% | 13.9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.94 | 58.46% | 68.59% | 91,097.88 | 5.36% | 13.54% |
|
NYSE:ZTS
Zoetis
|
169.04 | 30.88% | 47.09% | 77,132.13 | 1.03% | 11.19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
150.47 | 0% | 0% | 19,033.22 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
35.69 | 80.52% | 107.76% | 18,186.92 | 3.23% | -3.14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.16 | 5.13% | 15.66% | 13,324.53 | 4.28% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
264.27 | -10.71% | -1.33% | 11,803.71 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
55.81 | -57.4% | -7.04% | 10,130.94 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
62.10 | 0% | 0% | 6,707.63 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
39.08 | -,156.68% | -,149.23% | 5,756.54 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
156.43 | -9.31% | -0.59% | 5,026.29 | 0.51% | 5.85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
205.25 | 0% | 0% | 4,409.78 | 0% | 0% |
|
NYSE:PRGO
Perrigo Co PLC
|
30.71 | 35.16% | 58.3% | 4,186.4 | 3.56% | -10.73% |
|
NasdaqGS:NEOG
Neogen
|
12.33 | 133.55% | 233.03% | 2,692.43 | 0% | -1.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
27.04 | -34.78% | -10.92% | 2,552.83 | 0% | 2.03% |
